Dietary metal intake and the prevalence of erectile dysfunction in US men: Results from National Health and Nutrition Examination Survey 2001–2004

Background: Erectile dysfunction (ED) mainly affects men over 40 years of age and is a common clinical condition. In addition to hypertension and diabetes, environment, and lifestyle are also significantly associated with erectile dysfunction. The relationship between dietary trace metal intake and ED has not been studied.

Materials and methods: Data on participants were obtained from the National Health and Nutrition Examination Survey for this study, and those with incomplete information on clinical variables were excluded. Dose-response curve analysis was used to investigate the relationship between dietary trace metal intake and ED prevalence. Multivariate logistic regression analysis was used to adjust for confounders to further investigate the relationship between dietary trace metal intake and ED prevalence. 1:1 propensity score matching (PSM) was performed to adjust for differences between clinical variables for data reanalysis to confirm the reliability of the results.

Results: A total of 3,745 individuals were included in the study, including 1096 ED patients and 2,649 participants without ED. Dietary intake of trace metals (Mg, Zn, Cu, and Se) was significantly higher in participants without ED than in ED patients (all P < 0.001). Dose-response curve analysis showed a significant negative association between these dietary metal intakes and ED prevalence (all P < 0.001). Multivariate logistic regression analysis adjusted for confounders (age, education, BMI, annual household income, hypertension, diabetes, marital status, race, and current health status) revealed that increased dietary metal intake reduced the odds ratio of ED. 1:1 PSM reanalysis further confirmed the validity of the results.

Conclusion: Increasing dietary intake of trace metals (magnesium, zinc, copper, and selenium) within the upper limit is beneficial in reducing the prevalence of ED.

Introduction

Erectile dysfunction (ED) is a common clinical condition that commonly affects men over the age of 40. The National Institutes of Health (NIH) defines erectile dysfunction as the inability to maintain a sufficient penile erection over the course of a sexual relationship (1). Incidence of ED gradually increases with age. International Consultation Committee for Sexual Medicine on Definitions/Epidemiology/Risk Factors for Sexual Dysfunction states that the prevalence of ED in men less than 40 years of age is 1–10%. However, it increases to 20–40% in men aged 60–69 years, and ranges from 50 to 100% in those over 70 years (2–4). Another study showed that ED prevalence among men aged 60–69 years reached 46 per 1,000 person-years (5). As the world’s population ages, the prevalence of ED will be even higher, with 322 million cases expected by 2025 (6, 7).

Several studies have shown that ED is closely related to hypertension, diabetes, hyperlipidemia, and neurological disorders (8–10). Both vascular and neurological related lesions can lead to ED. Penile arteries are typically 1 to 2 mm in diameter, smaller than the 3 to 4 mm of coronary arteries and the 5 to 7 mm of carotid arteries. Therefore, atherosclerotic plaques of a smaller size should be more likely to obstruct and affect the hemodynamics of the penile arteries. In addition, vascular endothelial dysfunction may also be involved in ED (11). Some studies have also shown that certain environments and lifestyles are also important predictors of ED, such as smoking, caffeine intake, Vitamin D deficiency, lack of physical activity, etc., (12–15). Lifestyle and nutritional intake changes may improve ED (16–18).

Electrolyte balance in the human body is a prerequisite for normal physiological activity. Essential trace metals intake is beneficial to health. Trace metals are components of some important metalloenzymes, involved in antioxidant and cholesterol metabolism. Deficiency of trace metals can lead to stroke, atherosclerosis, thrombosis, hypertension, and other conditions (19). However, there is a lack of studies on the relationship of dietary metal intake and ED prevalence.

Materials and methods

Data sources and population

The study population was obtained from the National Health and Nutrition Examination Survey (NHANES), a program of studies designed to assess the health and nutritional status of non-institutionalized civilians in the United States.¹ The survey combines interviews and physical examinations involving a variety of health and nutrition measures. A nationally representative sample of approximately 5,000 individuals is surveyed each year, and interviews include demographic, socioeconomic, dietary, and health-related questions. The examination component includes medical, dental and physiological measurements conducted by trained medical personnel.

We obtained data of NHANES participants (men ≥ 20 years of age) between 2001 and 2004. Lack of relevant data was excluded: incomplete data on erectile dysfunction, incomplete data on dietary metal intake; unknown body mass index (BMI), unknown marital status, unknown education level, unknown annual household income, unknown current health status and hypertension/diabetes.

Study variables

Dietary metal intake data of interest (magnesium, zinc, copper, and selenium) were obtained for this study. The types and amounts of food and beverages consumed in the 24 h prior to the interview (midnight to midnight) were obtained from NHANES participants through dietary interviews. Then, the energy, nutrient, and other food components consumed from these foods and beverages were estimated by the USDA’s Food and Nutrient Database for Dietary Studies, 2.0 (FNDDS 2.0).

We also obtained other variables known or potentially associated with ED, such as age (less or more than 40 years), education level (less or more than a high school diploma), race (Mexican American, other Hispanic, non-Hispanic white, non-Hispanic black, other race), BMI (less or more than 25 kg/m²) annual household income (less or more than $20,000), marital status (yes/no), hypertension (yes/no), diabetes (yes, no, borderline), current health status (excellent, very good, good; fair or poor).

Erectile dysfunction assessment

According to Massachusetts Male Aging Study (MMAS) (20), trained interviewers asked male participants 20 years and older a single question to assess their ability to maintain an erection: “Many men experience problems with sexual intercourse. How would you describe your ability to get and keep an erection adequate for satisfactory intercourse?” Participants had the following options to describe their erectile response: “always able or almost always able to get and keep an erection,” “usually able to get and keep an erection,” “sometimes able to get and keep an erection,” “never able to get and keep an erection.” We define “sometimes able or never able” as having erectile dysfunction and “always or almost always able and usually able” as not having erectile dysfunction, which is consistent with previous studies (12, 13, 21, 22).

Statistical analysis

All statistical analyses were performed using R software (version 4.2.0) and SPSS (version 26). For categorical variables, data were described by frequency (n) and percentage (%). P values were analyzed by chi-square tests. For non-normally distributed continuous variables, data were described by interquartile range (IQR). P values were analyzed by Wilcoxon rank sum test. Multivariate logistic regression models were used to assess the relationship between different dietary metal intakes and ED, resulting in adjusted odds ratios (OR) and 95% confidence intervals (CI). Dose-response relationship between dietary metal intake and ED were described by restricted cubic spline (RCS) function. Subgroup analysis was also performed according to age, marital status and BMI.

Differences between ED and non-ED were balanced by 1:1 propensity score matching (PSM). Baseline characteristics were adjusting for confounding variables including: age, race, marital status, education level, BMI, hypertension, diabetes, annual household income, and current health status. The obtained PSM data were also re-analyzed to further test the correctness of the results. P value < 0.05 was considered statistically significant.

Results

Excluding participants with incomplete information, a total of 3,745 participants were included in the study, including 1096 (29.27%) ED patients and 2649 (70.73%) participants without ED (Figure 1). The number of people younger than 40 years of age with ED was only 73 (1.9%), and the percentage of people older than 40 years of age with ED was 27.3% (1023). In addition, participants with higher levels of education were less likely to have ED. Similarly, high income, health status, absence of hypertension and diabetes, and low BMI was associated with decreased ED incidence (Table 1). Interestingly, dietary magnesium, zinc, copper, and selenium intakes were significantly lower in ED patients than participants without ED (all P < 0.001).

FIGURE 1

Figure 1. Flow chart of the study population identification.

TABLE 1

Table 1. Baseline characteristics of national health and nutrition examination survey (NHANES) participants between 2001 and 2004 before propensity score matching (PSM).

Dose-response curve analysis of the RCS showed that dietary magnesium, zinc, copper, and selenium intake were negatively and non-linearly correlated with ED (all P < 0.001). The prevalence of ED decreased with increasing dietary trace metal intake (Figure 2). In addition, we performed subgroup analyses according to age, marital status, and BMI and obtained the same results, except in participants younger than 40 years. Interestingly, dietary magnesium, copper, and selenium (except zinc) intakes were not significantly associated with ED incidence in participants younger than 40 years of age but were significantly associated in participants older than 40 years of age (Table 2). Multivariate logistic regression models analysis adjusted for confounders (age, race, marital status, annual household income, education level, BMI, current health status, hypertension, diabetes) showed that the OR for ED decreased significantly with increased dietary intake of trace metals (Q1–Q4) (all P < 0.001) (Figure 3 and Table 3).

FIGURE 2

Figure 2. The dose-response analysis of dietary metal intake and erectile dysfunction before propensity score matching. (A) Magnesium; (B) Zinc; (C) Copper; and (D) Selenium.

TABLE 2

Table 2. Subgroup analysis of dietary metal intake and erectile dysfunction in national health and nutrition examination survey (NHANES) 2001–2004 before propensity score matching (PSM).

FIGURE 3

Figure 3. The adjusted odds ratios (95% CI) of dietary metal intake and erectile dysfunction before propensity score matching. (A) Magnesium; (B) Zinc; (C) Copper; and (D) Selenium.

TABLE 3

Table 3. Multivariate logistic regression analysis of the relationship between dietary metal intake and erectile dysfunction in national health and nutrition examination survey (NHANES) 2001–2004 before propensity score matching (PSM).

Differences (age, race, marital status, education level, BMI, hypertension, diabetes, annual household income, and current health status) between ED and non-ED were balanced by 1:1 PSM (Figure 4). After PSM, there were 896 ED patients and 896 participants without ED. Dietary metal (magnesium, zinc, copper, selenium) intake remained significantly higher in participants without ED than in ED patients (Table 4). After PSM reanalysis, dose-response curve analysis of RCS again verified that dietary intake of magnesium, zinc, copper, and selenium was negatively and non-linearly related to ED (Figure 5). Subgroup analyses by age, marital status, and BMI also showed a significant negative association between dietary trace metal intake and ED prevalence (except in participants younger than 40 years) (Table 5). After PSM, multivariate logistic regression analysis also resulted in a decrease in ED prevalence with increasing dietary trace metal intake (Figure 6 and Table 6). Food sources of trace metals and recommended upper limit were summarized and displayed in Table 7.

FIGURE 4

Figure 4. Propensity score matching analysis for treated and control population.

TABLE 4

Table 4. Baseline characteristics of national health and nutrition examination survey (NHANES) participants between 2001 and 2004 after propensity score matching (PSM).

FIGURE 5

Figure 5. The dose-response analysis of dietary metal intake and erectile dysfunction after propensity score matching. (A) Magnesium; (B) Zinc; (C) Copper; and (D) Selenium.

TABLE 5

Table 5. Subgroup analysis of dietary metal intake and erectile dysfunction in national health and nutrition examination survey (NHANES) 2001–2004 after propensity score matching (PSM).

FIGURE 6

Figure 6. The adjusted odds ratios (95% CI) of dietary metal intake and erectile dysfunction after propensity score matching. (A) Magnesium; (B) Zinc; (C) Copper; and (D) Selenium.

TABLE 6

Table 6. Multivariate logistic regression analysis of the relationship between dietary metal intake and erectile dysfunction in national health and nutrition examination survey (NHANES) 2001–2004 after propensity score matching (PSM).

TABLE 7

Table 7. Food sources of trace metals and recommended upper limit.

Discussion

Erectile dysfunction primarily affects men over the age of 40. Typical causes of ED are diabetes and hypertension. In addition, some common lifestyle factors such as obesity, lack of physical activity, and alcohol consumption are also reported to be associated with the development of ED. A strong association between ED and cardiovascular disease has been demonstrated, and it was indicated to be a promising predictor of coronary artery disease (8).

Currently, the number of studies on the relationship between dietary nutritional intake and ED prevalence are limited. The aim of this study was to investigate the relationship between dietary trace metal intake and erectile dysfunction. The results showed that dietary intake of magnesium, zinc, copper, and selenium was significantly lower in ED patients than participants without ED. Dose-response curve analysis of the RCS also found a negative correlation between dietary trace metal intake (magnesium, zinc, copper, and selenium) and ED prevalence. Interestingly, in the subgroup analysis, dietary metal intake was not significantly associated with ED prevalence in participants younger than 40 years. This suggests that dietary trace metal intake primarily affects ED prevalence in men over 40 years of age. Multivariate logistic regression model analysis adjusted for confounders also showed that increasing dietary metal intake significantly reduced the OR of ED. The 1:1 PSM reanalysis further confirmed the correctness of the above results.

Foods such as grains, green leafy vegetables, almonds, coffee and dark chocolate contain dietary magnesium, which is associated with many aspects of cardiovascular health (23, 24). Magnesium may play a protective role in vascular calcification. Higher magnesium intake reduces the risk of stroke, non-fatal myocardial infarction, sudden cardiac death and fatal coronary artery disease (25–27). Magnesium is an antagonist of calcium, reversing plaque formation and calcification by inhibiting hydroxyapatite and crystal precipitation (28, 29). Previous studies have reported a negative correlation between serum magnesium levels and calcification in the vascular bed, such as carotid intima-media thickness and pulse wave velocity (30, 31). Results from a cross-sectional study showed a 22% reduction in the risk of coronary calcification for every 50 mg increase in dietary magnesium intake (P < 0.001). Those with the highest intake were 58% less likely to have any coronary calcification compared to those with the lowest intake of magnesium (32). Therefore, increased dietary magnesium intake under recommended upper limit (420 mg/day) (33) may reduce the risk of penile artery calcification and thus reduce the prevalence of ED.

People can supplement their diets with dried fruits, meats, milk, cereals, and eggs for zinc need (34). Zinc is a component of many metalloenzymes and involved in the synthesis of angiotensin converting enzyme, copper/zinc superoxide dismutase (35, 36). Therefore, zinc deficiency may lead to oxidative stress and inflammation, which can result in cardiovascular events. In addition, some studies have reported that zinc may help prevent atherosclerosis and endothelial damage (35). Zinc deficiency releases proatherogenic factors that lead to increased carotid intima-media thickness (37). Zinc deficiency may contribute to erectile dysfunction through distal small arterial hypertension (penile arteries), oxidative stress, and damage to the vascular endothelium. Dietary zinc intake is recommended to be no more than 40 mg/day (38), and the results of this study suggest that increasing dietary zinc intake within this recommended range may be beneficial in reducing the risk of ED.

Nuts, legumes, and dark chocolate are copper-rich foods (34). Copper is essential for enzyme function, with its dual role as a pro-oxidant and an antioxidant (39). Copper is a catalytic cofactor for enzymes involved in the formation of enzymes such as copper/zinc superoxide dismutase (SOD), copper cyanobactin (CPO) and lysyl oxidase. Both copper deficiency and overload play a key role in the formation of atherosclerosis (40). Copper deficiency decreases SOD activity, which promotes the formation of hydroxyl radicals and leads to atherosclerosis (40). In addition, copper deficiency affects cholesterol metabolism. Its deficiency decreases dehydroepiandrosterone synthesis, leading to arterial oxidative damage and thrombosis (41). Copper overload allows it to exert pro-oxidant properties that increase atherosclerosis formation (42). Therefore, copper concentrations should be maintained in a reasonable range. Increasing dietary copper intake within reasonable limits may reduce the risk of oxidative damage and thrombosis in penile arteries. To avoid causing organ damage, dietary copper should be less than 10 mg/day (38).

Fish and seafood are rich in selenium and are a good choice for dietary selenium supplementation (34). Selenium is also an important trace mineral, a component of selenoprotein, which has significant antioxidant properties (43). Selenium can reduce atherosclerosis, stroke and other cardiovascular events by inhibiting the toxicity of heavy metals (mercury, silver, arsenic, and cadmium), lipid peroxidation, and increasing plasma glutathione and nitric oxide concentrations (44, 45). Increased dietary selenium intake may reduce ED prevalence within the recommended range of 400 mcg/day.

However, there are some limitations in this study. First: dietary information related to erectile dysfunction was included only in the 2001 to 2004 survey, which may differ from the current population. Second: The respondent population was US residents. Due to the difference in ethnic composition, the results may not be applicable to men from Asian countries. Third: Self-assessed erectile dysfunction is a weak point in this study due to the lack of medical validation.

In conclusion, trace metals are involved in preventing vascular damage, atherosclerosis and thus protecting relatively small diameter penile arteries through multiple pathways. Increasing dietary metal intake up to the recommended upper limit is beneficial in reducing the prevalence of erectile dysfunction.

Data availability statement

The original contributions presented in this study are included in the article/Supplementary material, further inquiries can be directed to the corresponding authors.

Author contributions

R-JL designed the study and conducted the data extraction and analysis. R-JL, W-PM, Z-PX, S-YL, J-JY, and BX wrote the manuscript. R-JL, W-PM, Z-PX, CS, BX, and MC reviewed and revised the manuscript. All authors contributed to the article and approved the submitted version.

Funding

This study was funded by the National Natural Science Foundation of China (Nos. 81871157, 81872089, 81370849, 81672551, 81300472, 81070592, 81202268, and 81202034); Six talent peaks project in Jiangsu Province, Jiangsu Provincial Medical Innovation Team (CXTDA2017025); and Natural Science Foundation of Jiangsu Province (BK20161434, BL2013032, BK20150642, and BK2012336).

Acknowledgments

We thank all authors for their support in this study.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fnut.2022.974443/full#supplementary-material

Footnotes

1. ^ https://www.cdc.gov/nchs/nhanes/index.htm

References

1. Consensus development conference statement. National institutes of health. Impotence. Int J Impot Res. (1993) 5:181–284.

Google Scholar

2. Nicolosi A, Moreira ED, Shirai M, Bin Mohd Tambi MI, Glasser DB. Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction. Urology. (2003) 61:201–6. doi: 10.1016/s0090-4295(02)02102-7

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Nicolosi A, Glasser DB, Kim SC, Marumo K, Laumann EO. GSSAB investigators’ group. Sexual behaviour and dysfunction and help-seeking patterns in adults aged 40-80 years in the urban population of Asian countries. BJU Int. (2005) 95:609–14. doi: 10.1111/j.1464-410X.2005.05348.x

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Pinnock CB, Stapleton Am Fau - Marshall VR, Marshall VR. Erectile dysfunction in the community: a prevalence study. Med J Aust. (1999) 171:353–7. doi: 10.5694/j.1326-5377.1999.tb123691.x

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the massachusetts male aging study. J Urol. (2000) 163:460–3. doi: 10.1016/S0022-5347(05)67900-1

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB. Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med. (2003) 139:161–8. doi: 10.7326/0003-4819-139-3-200308050-00005

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Ayta IA, McKinlay Jb Fau - Krane RJ, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int. (1999) 84:1464–4096. doi: 10.1046/j.1464-410x.1999.00142.x

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Inman BA, Sauver JL, Jacobson DJ, McGree ME, Nehra A, Lieber MM. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc. (2009) 84:108–13. doi: 10.4065/84.2.108

CrossRef Full Text | Google Scholar

9. Clark NG, Fox Km Fau - Grandy S, Grandy S. Symptoms of diabetes and their association with the risk and presence of diabetes: findings from the study to help improve early evaluation and management of risk factors leading to diabetes (SHIELD). Diabetes Care. (2007) 30:2868–73. doi: 10.2337/dc07-0816

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Gao X, Chen H, Schwarzschild MA, Glasser DB, Logroscino G, Rimm EB. Erectile function and risk of Parkinson’s disease. Am J Epidemiol. (2007) 166:1446–50. doi: 10.1093/aje/kwm246

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Montorsi P, Ravagnani PM, Galli S, Rotatori F, Briganti A, Salonia A. The artery size hypothesis: a macrovascular link between erectile dysfunction and coronary artery disease. Am J Cardiol. (2005) 96:19–23. doi: 10.1016/j.amjcard.2005.07.006

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Farag YMK, Guallar E, Zhao D, Kalyani RR, Blaha MJ, Feldman DI, et al. Vitamin D deficiency is independently associated with greater prevalence of erectile dysfunction: the national health and nutrition examination survey (NHANES) 2001-2004. Atherosclerosis. (2016) 252:61–7. doi: 10.1016/j.atherosclerosis.2016.07.921

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Lopez DS, Wang R, Tsilidis KK, Zhu H, Daniel CR, Sinha A, et al. Role of caffeine intake on erectile dysfunction in US men: results from NHANES 2001-2004. PLoS One. (2015) 10:e0123547. doi: 10.1371/journal.pone.0123547

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Silva AB, Sousa N, Azevedo LF, Martins C. Physical activity and exercise for erectile dysfunction: systematic review and meta-analysis. Br J Sports Med. (2017) 51:1419–24. doi: 10.1136/bjsports-2016-096418

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Shamloul R, Ghanem H. Erectile dysfunction. Lancet. (2013) 381:153–65. doi: 10.1016/S0140-6736(12)60520-0

CrossRef Full Text | Google Scholar

16. Allen MA-O. Physical activity as an adjunct treatment for erectile dysfunction. Nat Rev Urol. (2019) 16:553–62. doi: 10.1038/s41585-019-0210-6

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Mykoniatis I, Grammatikopoulou MG, Bouras E, Karampasi E, Tsionga A, Kogias A, et al. Sexual dysfunction among young men: overview of dietary components associated with erectile dysfunction. J Sex Med. (2018) 15:176–82. doi: 10.1016/j.jsxm.2017.12.008

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Kishimoto T, Kataoka T, Yamamoto Y, Asano G, Fukamoto A, Hotta Y, et al. High salt intake impairs erectile function in salt-sensitive rats through mineralocorticoid receptor pathway beyond its effect on blood pressure. J Sex Med. (2020) 17:1280–7. doi: 10.1016/j.jsxm.2020.04.384

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Mohammadifard N, Humphries KH, Gotay C, Mena-Sánchez G, Salas-Salvadó J, Esmaillzadeh A, et al. Trace minerals intake: risks and benefits for cardiovascular health. Crit Rev Food Sci Nutr. (2019) 59:1334–46. doi: 10.1080/10408398.2017.1406332

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Derby CA, Araujo AB, Johannes CB, Feldman HA, McKinlay JB. Measurement of erectile dysfunction in population-based studies: the use of a single question self-assessment in the massachusetts male aging study. Int J Impot Res. (2000) 12:197–204. doi: 10.1038/sj.ijir.3900542

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Selvin E, Burnett Al Fau - Platz EA, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med. (2007) 120:151–7. doi: 10.1016/j.amjmed.2006.06.010

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Liu C, Mao W, You Z, Xu B, Chen S, Wu J, et al. Associations between exposure to different heavy metals and self-reported erectile dysfunction: a population-based study using data from the 2001-2004 national health and nutrition examination survey. Environ Sci Pollut Res Int. (2022) 29:73946–56. doi: 10.1007/s11356-022-20910-x

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Bo S, Pisu E. Role of dietary magnesium in cardiovascular disease prevention, insulin sensitivity and diabetes. Curr Opin Lipidol. (2008) 19:50–6. doi: 10.1097/MOL.0b013e3282f33ccc

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Chakraborti S, Chakraborti T, Mandal M, Mandal A, Das S, Ghosh S. Protective role of magnesium in cardiovascular diseases: a review. Mol Cell Biochem. (2002) 238:163–79. doi: 10.1023/A:1019998702946

CrossRef Full Text | Google Scholar

25. Larsson SC, Orsini N Fau - Wolk A, Wolk A. Dietary magnesium intake and risk of stroke: a meta-analysis of prospective studies. Am J Clin Nutr. (2012) 95:362–6. doi: 10.3945/ajcn.111.022376

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Al-Delaimy WK, Rimm EB, Willett WC, Stampfer MJ, Hu FB. Magnesium intake and risk of coronary heart disease among men. J Am Coll Nutr. (2004) 23:63–70. doi: 10.1080/07315724.2004.10719344

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Chiuve SE, Korngold EC, Januzzi JL Jr., Gantzer ML, Albert CM. Plasma and dietary magnesium and risk of sudden cardiac death in women. Am J Clin Nutr. (2011) 93:253–60. doi: 10.3945/ajcn.110.002253

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Iseri Lt Fau - French JH, French JH. Magnesium: nature’s physiologic calcium blocker. Am Heart J. (1984) 108:188–93. doi: 10.1016/0002-8703(84)90572-6

CrossRef Full Text | Google Scholar

29. Laurencin D, Almora-Barrios N, de Leeuw NH, Gervais C, Bonhomme C, Mauri F, et al. Magnesium incorporation into hydroxyapatite. Biomaterials. (2011) 32:1826–37. doi: 10.1016/j.biomaterials.2010.11.017

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Massy ZA, Drüeke TB. Magnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survival. Clin Kidney J. (2012) 5:i52–61. doi: 10.1093/ndtplus/sfr167

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Salem S, Bruck H, Bahlmann FH, Peter M, Passlick-Deetjen J, Kretschmer A, et al. Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification. Am J Nephrol. (2012) 35:31–9. doi: 10.1159/000334742

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Hruby A, O’Donnell CJ, Jacques PF, Meigs JB, Hoffmann U, McKeown NM, et al. Magnesium intake is inversely associated with coronary artery calcification: the framingham heart study. JACC Cardiovasc Imaging. (2014) 7:59–69. doi: 10.1016/j.jcmg.2013.10.006

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Volpe SL. Magnesium in disease prevention and overall health. Adv Nutr. (2013) 4:378S–83S. doi: 10.3945/an.112.003483

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Filippini T, Cilloni S, Malavolti M, Violi F, Malagoli C, Tesauro M, et al. Dietary intake of cadmium, chromium, copper, manganese, selenium and zinc in a northern Italy community. J Trace Elem Med Biol. (2018) 50:508–17. doi: 10.1016/j.jtemb.2018.03.001

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Reiterer G, MacDonald R, Browning JD, Morrow J, Matveev SV, Daugherty A, et al. Zinc deficiency increases plasma lipids and atherosclerotic markers in LDL-receptor-deficient mice. J Nutr. (2005) 135:2114–8. doi: 10.1093/jn/135.9.2114

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Jurowski K, Szewczyk B, Nowak G, Piekoszewski W. Biological consequences of zinc deficiency in the pathomechanisms of selected diseases. J Biol Inorg Chem. (2014) 19:1069–79. doi: 10.1007/s00775-014-1139-0

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Munshi A, Babu S, Kaul S, Shafi G, Rajeshwar K, Alladi S, et al. Depletion of serum zinc in ischemic stroke patients. Methods Find Exp Clin Pharmacol. (2010) 32:433–6. doi: 10.1358/mf.2010.32.6.1487084

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Trumbo P, Yates AA, Schlicker S, Poos M. Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. J Am Dietet Assoc. (2001) 101:294–301.

Google Scholar

39. Al-Bayati MA, Jamil DA, Al-Aubaidy HA. Cardiovascular effects of copper deficiency on activity of superoxide dismutase in diabetic nephropathy. N Am J Med Sci. (2015) 7:41–6. doi: 10.4103/1947-2714.152077

PubMed Abstract | CrossRef Full Text | Google Scholar

40. Aliabadi H. A deleterious interaction between copper deficiency and sugar ingestion may be the missing link in heart disease. Med Hypotheses. (2008) 70:1163–6. doi: 10.1016/j.mehy.2007.09.019

PubMed Abstract | CrossRef Full Text | Google Scholar

41. DiSilvestro RA, Joseph EL, Zhang W, Raimo AE, Kim YM. A randomized trial of copper supplementation effects on blood copper enzyme activities and parameters related to cardiovascular health. Metabolism. (2012) 61:1242–6. doi: 10.1016/j.metabol.2012.02.002

PubMed Abstract | CrossRef Full Text | Google Scholar

42. Chen A, Li Y, Fau G, Liu Y. Association between copper levels and myocardial infarction: a meta-analysis. NHAL Toxicol. (2015) 27:237–46. doi: 10.3109/08958378.2015.1030480

PubMed Abstract | CrossRef Full Text | Google Scholar

43. Boosalis MG. The role of selenium in chronic disease. Nutr Clin Pract. (2008) 23:152–60. doi: 10.1177/0884533608314532

PubMed Abstract | CrossRef Full Text | Google Scholar

44. Hu XF, Eccles KM, Chan HM. High selenium exposure lowers the odds ratios for hypertension, stroke, and myocardial infarction associated with mercury exposure among inuit in Canada. Environ Int. (2017) 102:200–6. doi: 10.1016/j.envint.2017.03.002

PubMed Abstract | CrossRef Full Text | Google Scholar

45. Panchal SK, Wanyonyi S, Brown L. Selenium, vanadium, and chromium as micronutrients to improve metabolic syndrome. Curr Hypertens Rep. (2017) 19:1534–3111. doi: 10.1007/s11906-017-0701-x

PubMed Abstract | CrossRef Full Text | Google Scholar